Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 208

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

ORIGINAL ARTICLE: Antiphospholipid Antibodies Induce a Pro‐Inflammatory Response in First Trimester Trophoblast Via the TLR4/MyD88 Pathway

Open access
Mulla, Melissa J., Brosens, Jan J., Chamley, Larry W., Giles, Ian, Pericleous, Charis, Rahman, Anisur, Joyce, Shawna K., Panda, Britta, Paidas, Michael J., Abrahams, Vikki M. · 2009 · American Journal of Reproductive Immunology

Abstract

Problem Women with antiphospholipid antibodies (aPL) are at risk for recurrent miscarriage, pre‐eclampsia, and pre‐term labor. aPL target the placenta directly by binding to beta 2‐glycoprotein I (β 2 GPI) expressed on the surface of trophoblast cells. The objective of this study was to determine the effects of aPL on trophoblast function and the mechanisms involved. Method of study First trimester trophoblast cells were treated with anti‐β 2 GPI monoclonal antibodies and patient‐derived aPL, after which cell survival and function was evaluated. Results We report that anti‐β 2 GPI antibodies trigger an inflammatory response in trophoblast, characterized by increased secretion of interleukin (IL)‐8, MCP‐1, GRO‐α, and IL‐1β, and that this occurs in a TLR‐4/MyD88‐dependent manner. At high concentrations, these antibodies also induce caspase‐mediated cell death. This was attenuated upon disabling of the MyD88 pathway, suggesting that anti‐β 2 GPI‐induced inflammatory mediators compromise trophoblast survival by acting in an autocrine/paracrine manner. Enhanced IL‐8, GRO‐α, and IL‐1β secretion also occurred when trophoblast cells were incubated with antibodies from patients with antiphospholipid syndrome. Heparin, which acts as a pro‐survival factor in human trophoblast, attenuated the anti‐β 2 GPI antibody‐mediated cell death, and also the pro‐inflammatory response, but only at high concentrations. Conclusion These findings demonstrate that aPL triggers a placental inflammatory response via the TLR‐4/MyD88 pathway, which in turn compromises trophoblast survival. Thus, the TLR‐4/MyD88 pathway may provide a new therapeutic target to improve pregnancy outcome in antiphospholipid syndrome patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1600-0897.2009.00717.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 208

Metadata

Authors
Mulla, M. J., Brosens, J. J., Chamley, L. W., Giles, I., Pericleous, C., Rahman, A., Joyce, S. K., Panda, B., Paidas, M. J., & Abrahams, V. M.
Venue
American Journal of Reproductive Immunology
Publisher
Wiley
Published
2009-07-09
Volume
62
Issue
2
Pages
96-111
ISSN
  • 0271-7352 (ISSN-L)
  • 1046-7408
  • 1600-0897
OpenAlex
W1521045812
Cited by
208
References
4
FWCI
8.45
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ORIGINAL ARTICLE: Antiphospholipid Antibodies Induce a Pro‐Inflammatory Response in First Trimester Trophoblast Via the TLR4/MyD88 Pathway. https://app.cochat.ai/papers/10.1111/j.1600-0897.2009.00717.x
The paper
Mulla, M. J., Brosens, J. J., Chamley, L. W., Giles, I., Pericleous, C., Rahman, A., Joyce, S. K., Panda, B., Paidas, M. J., & Abrahams, V. M. (2009). ORIGINAL ARTICLE: Antiphospholipid Antibodies Induce a Pro‐Inflammatory Response in First Trimester Trophoblast Via the TLR4/MyD88 Pathway. American Journal of Reproductive Immunology. https://doi.org/10.1111/j.1600-0897.2009.00717.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.